“Today, WHO has included the Beijing Sinopharm vaccine in the list of drugs recommended for emergency use against COVID-19, which has become the sixth vaccine to receive certification from the WHO in terms of safety, efficacy and quality,” TASS quotes him.
Earlier, Gebreyesus, during a briefing, named the amount that will be required in 2022 to ensure vaccination against coronavirus infection for most of the adult population in the world.